hrcak mascot   Srce   HID

Izlaganje sa skupa

COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS

Pavo Filaković ; School of Medicine Osijek, University of Josip Juraj Strossmayer, Osijek, Croatia
Anamarija Petek ; Psychiatric Clinic, Clinical Hospital Osijek, Osijek, Croatia
Oliver Koić ; School of Medicine Osijek, University of Josip Juraj Strossmayer, Osijek, Croatia
Ljiljana Radanović-Grgurić ; Psychiatric Clinic, Clinical Hospital Osijek, Osijek, Croatia
Dunja Degmečić ; School of Medicine Osijek, University of Josip Juraj Strossmayer, Osijek, Croatia

Puni tekst: engleski, pdf (281 KB) str. 401-410 preuzimanja: 603* citiraj
APA 6th Edition
Filaković, P., Petek, A., Koić, O., Radanović-Grgurić, Lj. i Degmečić, D. (2009). COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS. Psychiatria Danubina, 21 (3), 401-410. Preuzeto s https://hrcak.srce.hr/49307
MLA 8th Edition
Filaković, Pavo, et al. "COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS." Psychiatria Danubina, vol. 21, br. 3, 2009, str. 401-410. https://hrcak.srce.hr/49307. Citirano 28.03.2020.
Chicago 17th Edition
Filaković, Pavo, Anamarija Petek, Oliver Koić, Ljiljana Radanović-Grgurić i Dunja Degmečić. "COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS." Psychiatria Danubina 21, br. 3 (2009): 401-410. https://hrcak.srce.hr/49307
Harvard
Filaković, P., et al. (2009). 'COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS', Psychiatria Danubina, 21(3), str. 401-410. Preuzeto s: https://hrcak.srce.hr/49307 (Datum pristupa: 28.03.2020.)
Vancouver
Filaković P, Petek A, Koić O, Radanović-Grgurić Lj, Degmečić D. COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS. Psychiatria Danubina [Internet]. 2009 [pristupljeno 28.03.2020.];21(3):401-410. Dostupno na: https://hrcak.srce.hr/49307
IEEE
P. Filaković, A. Petek, O. Koić, Lj. Radanović-Grgurić i D. Degmečić, "COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS", Psychiatria Danubina, vol.21, br. 3, str. 401-410, 2009. [Online]. Dostupno na: https://hrcak.srce.hr/49307. [Citirano: 28.03.2020.]

Sažetak
Depressive disorders are more common in the population affected with dermatologic disorders. Comorbidity of depression and dermatologic disorders is around 30%. The correlation between depressive and dermatologic disorders still remains unclear. In psychodermatology three disorders are described:
a) psychophysiological disorders (both disorders induced and maintained by stressors),
b) secondary psychiatric disorders (mental disorder as a result of skin leasions and treatment) and
c) primary psychiatric disorders (skin alterations as a result of
mental disorders and treatment). In depression and dermatology disorders in which certain precipitating factors are required thereby causing alteration of the patient's immunological identity causing a combination of hereditary features and ones acquired through adaptation occur to cause the disorder to develop. The cytokines
are vital in the regulation of the immunology response and are also mediators of non-infective inflammatory processes leading to recurrent hormonal secretion affecting the function of the vegetative and central nervous system leading to so called „sickness behaviour“, marked by loss of appetite, anhedonia, anxiety,
decrease of concentration and interest along with other changes which generate a picture of depressive disorder. Treatment of depressive and dermatologic disorders is complex and requires an integral therapeutic approach encompassing all aspects
of both disorders and their comorbidity. Therefore therapeutic success lies in a team approach to the patient under the auspice of consultative-liason psychiatry by setting the frame for efficient collaboration and bridging the gap between the mental
and the physical in everyday clinical practice.

Ključne riječi
depressive disorders; dermatologic disorders; comorbidity; therapeutic aspects

Hrčak ID: 49307

URI
https://hrcak.srce.hr/49307

Posjeta: 899 *